Biomarkers for cardiovascular risk prediction: from pioneering to evidence-based use in clinical practice
Crossref DOI link: https://doi.org/10.1007/s12471-022-01737-0
Published Online: 2022-11-15
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hemels, M. E. W. http://orcid.org/0000-0002-2373-9858
Text and Data Mining valid from 2022-11-15
Version of Record valid from 2022-11-15
Article History
Accepted: 20 October 2022
First Online: 15 November 2022
Conflict of interest
: M.E.W. Hemels declares that the Dutch-GERAF study is in part funded by Roche Diagnostics.